2Tiemei Z, Xiangqun F, Youning L. Resistance phenotypes and genotypes of erythromycin-resistant streptococcus pneumonia isolates in Beijing and Shenyang, China. Antimicrob Agents Chemother,2004,10:4040-4041.
3Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator associated pneumonia. Am J Respir Crit Care Med, 1997,156 : 196-200.
4Garau J.Beta - lactamases:Current situation and clinical importace.Intensive Care Med,1994,20:S5
4Gaillat J, Flahault A, de Barbeyrac B, et al.Community epidemiology of chlamydia and mycoplasma pneumoniae in LRTI in France over 29 months[J].European Journal of Epidemiology, 2005, 20 ( 7 ) : 643- 651.
5Macfarlane J, Holmes W, Gard P, et al.Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the eommunity[J].Thorax, 2001, 56 ( 2 ) : 109-114.
6Nagalingam N A, Adesiyun A A, Swanston W H, et al.Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in pneumonia patients in four major hospitals in Trinidad[J].The New Microbiologica, 2004, 27 ( 4 ) : 345-351.
7Noyola D E, Arteaga-Domtnguez G.Contribution of respiratory syncytial virus, influenza and parainfluenza viruses to acute respiratory infections in San Luis Potosi, Mexico[J].The Pediatric Infectious Disease Journal, 2005, 24 ( 12 ) : 1049-1052.
8Clinical and Laboratory Standards Institute (CLSI). M100-S20 Performance Standards for Antimicrobial Susceptibility Testing; Twentieth informational supplement [ S ]. Wayne, PA : CLSI, 2010.
9Watkins RR, Lemonovich TL. Diagnosis and management of community-acquired pneumonia in adults [ J ]. Am Fam Physician, 2011, 83(11 ) :1299-1306.
